Cost Effectiveness of Representatives of Three Classes of Antidepressants Used in Major Depression in the UK
Year of publication: |
2004
|
---|---|
Authors: | Lenox-Smith, Alan ; Conway, Pete ; Knight, Chris |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 22.2004, 5, p. 311-319
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Amitriptyline | Cost-effectiveness | Depression | Serotonin-reuptake-inhibitors | Tricyclic-antidepressants | Venlafaxine |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Machado, Marcio, (2007)
-
Remission from Depression: A Review of Venlafaxine Clinical and Economic Evidence
Han, Donald, (2005)
-
Mirtazapine: A Pharmacoeconomic Review of its Use in Depression
Holm, Kristin J., (2000)
- More ...
-
McEwan, Phil, (2006)
-
Pharmacoeconomic Analysis of Antidepressants for Major Depressive Disorder in the United Kingdom
Freeman, Hugh, (2000)
-
Cost-effectiveness of treatment with etanercept for psoriasis in Sweden
Knight, Christopher, (2012)
- More ...